InsiderTrades

Form 4 for AGL agilon health, inc.

Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-14 · accession 0001209191-21-056202 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-09-15 2021-09-14 AGL Halkias Theodore Chief Business Off M - OptEx $1.00 +58.6K 64.0K +1,078% +$58.6K
D 2021-09-15 2021-09-14 AGL Halkias Theodore Chief Business Off S - Sale+OE $28.98 -58.6K 5,434 -92% -$1.70M
DI 2021-09-15 2021-09-14 AGL Halkias Theodore Chief Business Off S - Sale+OE $28.98 -100.0K 0 -100% -$2.90M
D 2021-09-15 2021-09-14 AGL Halkias Theodore Chief Business Off M - OptEx $0.00 -58.6K 1.74M -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-14 M A 58,553 $1.00 63,987 D By trust — — (F1) Includes restricted stock units. (F2) These shares of common stock were held in the Halkias Irrevocable Trust.
2 Common Common Stock 2021-09-14 S D 58,553 $28.98 5,434 D — — (F1) Includes restricted stock units.
3 Common Common Stock 2021-09-14 S D 100,000 $28.98 0 I — —
4 Derivative Options (Rights to Buy) 2021-09-14 M D 58,553 $0.00 1,741,447 D $1.00 · — to 2027-04-27 58,553 Common Stock (F3) These options were granted on April 27, 2017, and fully vested on May 15, 2017.